Login to Your Account



Glivec declared drug of public interest by Colombian government

By Sergio Held
Staff Writer

Thursday, June 16, 2016

BOGOTA, Colombia – The Colombian government will set the price of Novartis AG's cancer drug Glivec after failing to reach an agreement with the company following price talks that started in April.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription